Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers : A Randomized Double-blind Placebo-controlled Clinical Trial

NCT04328285 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Saint Etienne as lead sponsor.

NCT NCT04328285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04328285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers : A Randomized Double-blind Placebo-controlled Clinical Trial
Lead sponsor
Centre Hospitalier Universitaire de Saint Etienne
Phase
Phase 3
Overall status
Terminated
Start date
April 14, 2020
Completion date
March 30, 2022
Enrollment
118 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19